Candiani Talitah M S, Pinto Jorge, Cardoso Claudete A Araújo, Carvalho Inácio R, Dias Arlete C M, Carneiro Mariângela, Goulart Eugênio A
Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Cad Saude Publica. 2007;23 Suppl 3:S414-23. doi: 10.1590/s0102-311x2007001500009.
The impact of highly active antiretroviral therapy (HAART) can be evaluated using indicators, such as rates of opportunistic infections, hospitalizations by cause of infection, and associated death. This study aimed to estimate the impact of HAART on the incidence of these indicators, in children and adolescents with HIV/AIDS. It was a hybrid cohort study; 371 patients were followed from 1989 to 2003. In December 2003, 76% of the patients were still being followed, while 12.1% had died, 9.5% had dropped out, and 2.4% had been transferred. The overall rate of opportunistic infections was 18.32 infections/100 persons-year and 2.63 in the pre- and post-HAART periods, respectively. In the multivariate analysis, the risk of developing an opportunistic infection was 5.4 times greater and 3.3 times greater for hospitalization risk before HAART. Respiratory causes represented 65% of the hospitalizations and they were reduced by 44.6% with therapeutic intervention. The average hospital stay of 15 days was reduced to 9. There was a post-HAART decline in deaths of 38%. This study demonstrates the effectiveness of HAART in significantly reducing opportunistic infections, hospitalizations, and deaths in this Brazilian cohort.
高效抗逆转录病毒疗法(HAART)的影响可以通过一些指标来评估,如机会性感染率、因感染原因住院率以及相关死亡率。本研究旨在评估HAART对感染艾滋病毒/艾滋病的儿童和青少年中这些指标发生率的影响。这是一项混合队列研究;1989年至2003年对371名患者进行了随访。2003年12月,76%的患者仍在接受随访,12.1%的患者已经死亡,9.5%的患者退出,2.4%的患者已被转移。机会性感染的总发生率为18.32次感染/100人年,在HAART治疗前和治疗后分别为2.63次感染/100人年。在多变量分析中,HAART治疗前发生机会性感染的风险高5.4倍,住院风险高3.3倍。呼吸道原因占住院病例的65%,通过治疗干预减少了44.6%。平均住院天数从15天减少到9天。HAART治疗后死亡人数下降了38%。本研究证明了HAART在显著降低该巴西队列中的机会性感染、住院率和死亡率方面的有效性。